Peptide Units Vs Mg
Peptide Units vs mg: The Syringe Conversion Math
The short answer
This page is general educational information, research-use framing only, not medical advice. Any decision about a research compound belongs with a qualified clinician.
TL;DR
- "mg" and "mcg" measure mass, while a "unit" on an insulin syringe measures volume, not mass; on a U-100 syringe, 100 units equals 1 mL. - 1 mg equals 1000 mcg. This is a fixed definition, not a number that changes by peptide. - The reference formula is: mcg per unit = (mg in the vial × 10) / mL of bacteriostatic water added. This is reference math, not an instruction to dose. - IU measures biological activity set by a reference standard, not mass, so there is no single mg-to-IU factor that works across substances. - Research reports amounts in mass. For example, the STEP 1 trial reported semaglutide 2.4 mg once weekly with a mean weight change of about -14.9 percent at week 68 (Wilding et al., NEJM 2021).
Peptide units vs mg: why are both used?
Because "mg" describes how much peptide is present by mass, and a "unit" describes how much liquid you have drawn on an insulin syringe. That is the heart of peptide units vs mg: one is mass, the other is volume.
These two numbers answer different questions. Milligrams (mg) and micrograms (mcg) are mass, the actual quantity of peptide. A syringe "unit" is a volume mark printed on the barrel. Once a dry peptide is mixed with liquid, the same number of units can hold very different amounts of peptide, depending on how much liquid was added. That is the whole source of confusion, and it is solved with arithmetic, not opinion.
Research studies almost always report amounts in mass because mass is what was actually given. As examples, the STEP 1 trial reported semaglutide 2.4 mg once weekly with a mean weight change of about -14.9 percent at week 68 (Wilding et al., NEJM 2021; doi:10.1056/NEJMoa2032183), and SURMOUNT-1 reported tirzepatide at 5, 10, and 15 mg once weekly with a mean weight change up to about -22.5 percent at week 72 for the 15 mg group (Jastreboff et al., NEJM 2022; doi:10.1056/NEJMoa2206038). None of these were reported in "units," because units only describe the volume in a syringe, not the drug.
What does a "unit" mean on an insulin syringe?
A "unit" is a volume mark, and on the common U-100 syringe, 100 units equals exactly 1 mL.
The "U" number tells you units per mL. On a U-100 syringe, 1 mL is divided into 100 units, so a single unit is 0.01 mL, which is 10 microliters. Some syringes use a different scale, so the barrel label matters.
| Syringe marking | Units per mL | Volume of 1 unit |
|---|---|---|
| U-100 | 100 | 0.01 mL |
| U-40 | 40 | 0.025 mL |
The key idea: a unit is a fixed volume for a given syringe. It says nothing about how much peptide is in that volume until you know the concentration.
How do mg and mcg relate?
They are both units of mass, and 1 mg equals 1000 mcg.
This never changes. A milligram is one thousandth of a gram, and a microgram is one millionth of a gram, so a milligram is 1000 micrograms. Vials are usually labeled in mg (for example, a 5 mg vial), while research amounts are often written in mcg because the numbers are smaller and easier to read. Converting between them is just multiplying or dividing by 1000.
- 1 mg = 1000 mcg - 0.5 mg = 500 mcg - 0.25 mg = 250 mcg
Where does IU fit in, and can you convert mg to IU?
IU measures biological activity defined by a reference standard, not mass, so there is no universal mg-to-IU conversion.
IU stands for International Unit. It is used for some biologics where activity, not weight, is the standardized measure. Because each substance has its own reference standard, the relationship between mg and IU is specific to that substance and cannot be assumed. If a product is labeled in IU, treat that as its own scale and do not try to convert it with a generic factor. When a peptide is labeled by mass, the unit-conversion math below applies; when it is labeled in IU, it does not.
How do you convert mg to units after reconstitution?
Reconstitution means dissolving the dry peptide in bacteriostatic water, and once you know the concentration, the syringe mark follows from simple arithmetic.
The following is reference math for converting between mass and syringe marks. It is not an instruction to dose, it does not tell you how much to draw, and it is not medical advice. Any personal amount belongs with a qualified clinician.
Two steps:
1. Concentration: divide the peptide mass by the volume of water you added. Concentration (mcg per mL) = (mg in vial × 1000) / mL of water added. 2. Per unit: because 1 unit on a U-100 syringe is 0.01 mL, multiply the concentration by 0.01. mcg per unit = concentration (mcg per mL) × 0.01.
Combined into one line:
mcg per unit = (mg in vial × 10) / mL of bacteriostatic water added.
The bacteriostatic water adds volume, not peptide. So the more water you add, the lower the concentration, and the fewer mcg sit under each unit mark. The peptide mass in the vial never changes; only how it is spread across the liquid changes.
What does the conversion look like in a worked example?
Here is the same formula applied across common vial sizes and water volumes, as reference only.
The ranges below reflect what published studies and commonly studied research protocols report. This is educational, not a prescription or a personal recommendation. The vial sizes and water volumes in the table are illustrative inputs to the arithmetic, not amounts to use.
Take a 5 mg vial mixed with 2 mL of bacteriostatic water. Concentration is 5 × 1000 / 2 = 2500 mcg per mL. Per unit that is 2500 × 0.01 = 25 mcg per unit. Ten units would therefore hold 250 mcg.
| Vial (mg) | Water added (mL) | Concentration (mcg/mL) | mcg per unit (U-100) | mcg per 10 units |
|---|---|---|---|---|
| 2 | 1 | 2000 | 20 | 200 |
| 5 | 1 | 5000 | 50 | 500 |
| 5 | 2 | 2500 | 25 | 250 |
| 10 | 1 | 10000 | 100 | 1000 |
| 10 | 2 | 5000 | 50 | 500 |
Read the table as reference arithmetic, not as a suggestion of any amount to use. Notice how the 5 mg vial gives 50 mcg per unit with 1 mL of water but only 25 mcg per unit with 2 mL: same peptide, different concentration, different mark.
Why does the same mg land on a different syringe mark?
Because a unit reads volume, and adding more water spreads the same mass across more liquid.
This is the most common mix-up. Two people can both have a 10 mg vial and both draw to "10 units," yet hold different amounts of peptide, because one added 1 mL of water and the other added 2 mL. From the table, 10 units of the 10 mg / 1 mL mix is 1000 mcg, while 10 units of the 10 mg / 2 mL mix is 500 mcg. The syringe mark is identical; the mass is not. This is why a research amount reported in mg or mcg only becomes a syringe mark after you fix the concentration.
Do research papers report peptides in units or mg?
Almost always in mass, because mass is what was administered and measured.
Trials name amounts in mg or mcg. Tesamorelin, reported in milligrams per day, was linked to a visceral adipose tissue drop of about 15 percent versus a rise on placebo (Falutz et al., NEJM 2007; doi:10.1056/NEJMoa072375). Growth hormone secretagogues such as CJC-1295 were studied for sustained GH and IGF-1 responses (Teichman et al., JCEM 2006), and ipamorelin was described as a selective GH secretagogue (Raun et al., Eur J Endocrinol 1998; doi:10.1530/eje.0.1390552), again with amounts framed by mass. For some research peptides, human dosing data is very limited; BPC-157, for instance, is dominated by animal studies rather than completed human dose-finding trials (Sikiric et al., review, PMC7096228). The point stands: the literature speaks in mass, and syringe units are only the volume that happens to carry that mass.
FAQPage JSON-LD
Keep reading
Related research and verification
Peptide Units Vs Mg: FAQ
References
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (STEP 1). New England Journal of Medicine. 2021;384:989-1002. doi:10.1056/NEJMoa2032183. PMID 33567185.
- Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity" (SURMOUNT-1). New England Journal of Medicine. 2022;387:205-216. doi:10.1056/NEJMoa2206038. PMID 35658024.
- Falutz J, et al. "Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV." New England Journal of Medicine. 2007;357:2359-2370. doi:10.1056/NEJMoa072375.
- Teichman SL, et al. "Prolonged Stimulation of GH and IGF-1 Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults." Journal of Clinical Endocrinology and Metabolism. 2006;91(3):799-805.
- Raun K, et al. "Ipamorelin, the first selective growth hormone secretagogue." European Journal of Endocrinology. 1998;139(5):552-561. doi:10.1530/eje.0.1390552.
- Sikiric P, et al. "Stable Gastric Pentadecapeptide BPC 157: Progress, Achievements, and the Future" (review). PMC7096228.
General educational information only, research-use framing, not medical advice. Confirm the current status where you live and consult a qualified professional before acting.